Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
History, Companies & Products
Explore the main themes, entities and connections around Methylhexanamine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug positive 2012 dietary testing dmaa products banned supplement supplements also use safety substance 2013 suspended market events us sports
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Methylhexanamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Methylhexanamine | ATC code | None | 1.00 | infobox |
| Methylhexanamine | CAS Number | 105-41-9 Y | 1.00 | infobox |
| Methylhexanamine | ChemSpider | 7467 N | 1.00 | infobox |
| Methylhexanamine | CompTox Dashboard (EPA) | DTXSID60861715 | 1.00 | infobox |
| Methylhexanamine | ECHA InfoCard | 100.002.997 | 1.00 | infobox |
| Methylhexanamine | Elimination half-life | ~8.5 hours | 1.00 | infobox |
| Methylhexanamine | Formula | C7H17N | 1.00 | infobox |
| Methylhexanamine | Legal status | AU: S10 (Dangerous substance) | 1.00 | infobox |
| Methylhexanamine | Legal status | BR: Class F2 (Prohibited psychotropics) | 1.00 | infobox |
| Methylhexanamine | Legal status | US: Unapproved drug; use in dietary supplements, food, or medicine is unlawful.[note 1] | 1.00 | infobox |
| Methylhexanamine | Molar mass | 115.220 g·mol−1 | 1.00 | infobox |
| Methylhexanamine | Other names | Methylhexaneamine, methylhexamine, geranamine, geranium extract, geranium oil, 2-amino-4-methylhexane, dimethylamylamine, DMAA, 1,3-dimethylamylamine, 1,3-DMAA, 1,3-dimethylpent… | 1.00 | infobox |
| Methylhexanamine | PubChem CID | 7753 | 1.00 | infobox |
| Methylhexanamine | Routes of administration | Nasal spray, oral | 1.00 | infobox |
| Methylhexanamine | UNII | X49C572YQO | 1.00 | infobox |
| Methylhexanamine | is a | indirect sympathomimetic drug that constricts blood vessels and thus has effects on the heart | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.